CATALYST DOSSIER · UPDATED 2026-11-09
$ENVX
tech · convergence 6 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $ENVX?
Quantitative
Net Income (CY2026Q2) : $-43.1M (+329.0% YoY)
Catalysts
Corporate action : warrant_exercise 2026-10-28
Corporate action : special_dividend 2026-10-28
Risks
Hard-to-borrow / FTD risk : Borrow rate 6.0%, distress score 30
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
IONS via biotech r=+0.98 sympathetic (score 30)
OCUL via biotech r=+0.98 sympathetic (score 28)
NVDA via semis r=+0.96 sympathetic (score 32)
DIOD via semis r=+0.96 sympathetic (score 18)
CNH via industrials r=+0.75 sympathetic (score 33)
RAIL via industrials r=+0.75 sympathetic (score 17)
Signals Firing
earnings finra_short finra_regsho ftd audit_extras auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-28 sec_top_gappers +1.4% -0.3% — 2026-10-28 sec_top_moat_emerging +1.4% -0.3% — 2026-10-16 sec_top_gappers +3.0% -5.6% ✓ hit 2026-10-16 sec_top_moat_emerging +3.0% -5.6% ✓ hit
Lifetime: 2/4 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket IONS via biotech · score 30 OCUL via biotech · score 28 NVDA via semis · score 32 DIOD via semis · score 18 CNH via industrials · score 33 RAIL via industrials · score 17
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.